FORMULARY WATCH

Diabetes

FDA: Joint pain linked to DPP-4 inhibitors for diabetes

By Christine Blank
FDA warned that several leading drugs for type 2 diabetes may cause severe and disabling joint pain. Drugs that have new risk warning

FDA approves Synjardy for type 2 diabetes

By Erin Bastick
FDA approved empagliflozin and metformin hydrochloride (Synjardy, Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company) tablets for the treatment of adults with type 2 diabetes. How it works

CONTINUING EDUCATION

Primer on inhalers and nebulizers

This month's CE activity is part of the CPE series, Medication Therapy Management for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss the various types of inhaled devices and educate pharmacists on the techniques for correct device use.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT33-FTX29.

The login to the Online CE Center is
https://web2.uconn.edu/pharmacyce/login.php.
All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to
https://web2.uconn.edu/pharmacyce/program_register.php.
For a full list of courses, go to
http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce

Top 5 fastest-growing drug firms

by Christine Blank
Surprisingly, the top pharmaceutical manufacturer on Fortune's Fastest-Growing Companies ranking for 2015 makes generic drugs and, unsurprisingly, Gilead Sciences, also ranks in the top 10. Read more

September 4, 2015